Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Non-cancer endpoints in BRCA1/2 carriers after risk-reducing salpingo-oophorectomy.

Familial cancer - 1 Mar 2012

Cohen J V, Chiel L, Boghossian L, Jones M, Stopfer J E, Powers J, Rebbeck T R, Nathanson K L, Domchek S M

Abstract excerpt

Risk-reducing salpingo-oophorectomy (RRSO) significantly reduces the risk of ovarian cancer and breast cancer in pre-menopausal women with BRCA1 and BRCA2 (B1/2) mutations. Despite its clear benefits, little is known about non-cancer endpoints in this population. Medical records were examined in...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Bone Diseases, Metabolic
Share to Hyperlipidemias
Share to Hypothyroidism

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Medical Records

Share to Osteoporosis

Share to Ovariectomy

Share to Postoperative Complications

Share to Risk Reduction Behavior

Source

Identifiers

PMID: 21898151
DOI: 10.1007/s10689-011-9480-8

Genes

BRCA1
CAD
BRCA2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-21898151-2026-09-04.1. Manifest publication-graph-cohort-2026-09-04.1.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Non-cancer endpoints in BRCA1/2 carriers after risk-reducing salpingo-oophorectomy.PMID 21898151Read ↗

Osteoporosis risk and management in BRCA1 and BRCA2 carriers who undergo risk-reducing salpingo-oophorectomy.Semantic proximity Read ↗

Bone health after RRBSO among BRCA1/2 mutation carriers: a population-based study.Semantic proximity Read ↗

Risk of cardiovascular disease among women carrying BRCA mutations after risk-reducing bilateral salpingo-oophorectomy: A population-based study.Semantic proximity Read ↗

Menopausal symptoms and bone health in women undertaking risk reducing bilateral salpingo-oophorectomy: significant bone health issues in those not taking HRT.Semantic proximity Read ↗

Female reproductive factors, genetic susceptibility and incident osteoporosis risk.Semantic proximity Read ↗

Endocrine-related osteoporosis: bone quality, clinical phenotype, and targeted management.Semantic proximity Read ↗

Care after premenopausal risk-reducing salpingo-oophorectomy in high-risk women: Scoping review and international consensus recommendations.Semantic proximity Read ↗

Dealing with premature menopause in women at high-risk for hereditary genital and breast cancer.Semantic proximity Read ↗

Metabolic syndrome after risk-reducing salpingo-oophorectomy in women at high risk for hereditary breast ovarian cancer: a controlled observational study.Semantic proximity Read ↗

Changes in Bone Density in Carriers of BRCA1 and BRCA2 Pathogenic Variants After Salpingo-Oophorectomy.Semantic proximity Read ↗

Hormone therapy after risk-reducing surgery in patients with BRCA1/BRCA2 mutation: evaluation of potential benefits and safety.Semantic proximity Read ↗

Cholesterol profile in women with premature menopause after risk reducing salpingo-oophorectomy.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.